ID: ALA4283279

Max Phase: Preclinical

Molecular Formula: C12H20N2O3

Molecular Weight: 240.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC12CC3CC(N)(C1)CC(CO[N+](=O)[O-])(C3)C2

Standard InChI:  InChI=1S/C12H20N2O3/c1-10-2-9-3-11(5-10,8-17-14(15)16)7-12(13,4-9)6-10/h9H,2-8,13H2,1H3

Standard InChI Key:  NOJAUKMHWIYJOH-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 240.30Molecular Weight (Monoisotopic): 240.1474AlogP: 1.88#Rotatable Bonds: 3
Polar Surface Area: 78.39Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.69CX LogP: 1.48CX LogD: -1.36
Aromatic Rings: 0Heavy Atoms: 17QED Weighted: 0.60Np Likeness Score: 0.18

References

1. Liu Z, Yang S, Jin X, Zhang G, Guo B, Chen H, Yu P, Sun Y, Zhang Z, Wang Y..  (2017)  Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases.,  (1): [PMID:30108699] [10.1039/C6MD00509H]

Source